pharma innovation at korea - İeİs...unit : usd billion korea pharmaceutical market source: kfda...
TRANSCRIPT
![Page 1: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/1.jpg)
October 23, 2014
Dahee JEONG
Director of Bio-Medical Industry, Investment Promotion Department
Invest Korea , KOTRA
Pharma Innovation at Korea
- Business Opportunities in Korea -
![Page 2: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/2.jpg)
Source: KOREA TOURISM ORGANIZATIONLocation: Traditional Korean Houses, Seoul
![Page 3: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/3.jpg)
Source: KOREA TOURISM ORGANIZATION
Location: Gyeonghwaeroo at Gyeongbokgung Palace
![Page 4: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/4.jpg)
Source: KOREA TOURISM ORGANIZATIONLocation: Haeinsa Temple, Hapcheon
![Page 5: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/5.jpg)
Source: KOREA TOURISM ORGANIZATIONSeokguram, UNESCO World Heritage
![Page 6: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/6.jpg)
Source: KOREA TOURISM ORGANIZATIONLocation: Seorak Mountain
![Page 7: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/7.jpg)
Location: Seorak Mountain
![Page 8: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/8.jpg)
Location: Bulkuk Temple in Gyeongju
![Page 9: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/9.jpg)
Source: KOREA TOURISM ORGANIZATIONLocation: God’s Playground at Seorak Mountain
![Page 10: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/10.jpg)
Source: KOREA TOURISM ORGANIZATIONLocation: Yeongwol-gun
![Page 11: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/11.jpg)
Source: KOREA TOURISM ORGANIZATIONLocation: Sol Island, Kangwon Province
![Page 12: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/12.jpg)
Source: KOREA TOURISM ORGANIZATIONLocation: Ole Trail, Jeju Island
![Page 13: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/13.jpg)
Source: KOREA TOURISM ORGANIZATIONLocation: Ecological Park, Suncheon Bay
![Page 14: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/14.jpg)
Source: KOREA TOURISM ORGANIZATIONLocation: Jeju Island
![Page 15: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/15.jpg)
15
![Page 16: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/16.jpg)
Free Trade Agreements of Korea
In Effect Concluded Under WayUSA, EU, Chile,
Singapore, EFTA,ASEAN, India, Peru, Turkey
Australia, Canada, Colombia
ChinaIndonesia, Vietnam,Korea-China-Japan
FTA in present : 61% of global economy
Singapore
Chile
USA
IndiaKorea
EFTA
EUTurkey
PeruASEAN
Colombia
Geographical Landscape Expansion 16
61% of world GDP, 46.2% of world trade volume, 39.7% of world population
![Page 17: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/17.jpg)
* Source : Bloomberg, 2014
Korea, the innovation center
Country R&Dintensity
Mfging capability
High-techdensity
Tertiaryefficiency
Researcherconcentration
Patent activity
1 S. Korea 3 2 3 3 6 2
2 Sweden 4 22 5 13 8 26
3 USA 10 24 1 37 12 5
4 Japan 5 6 8 30 9 3
5 Germany 9 3 6 25 17 6
R&D intensity : R&D expenditure as a percentage of GDPMfging capability : Mfgring value-added as a percentage of GDP and as a share of world total mfging value-addedHigh-tech density : Number of high-tech public companies as a percentage of all publicly listed companiesTertiary efficiency : Annual science and engineering graduates as a percentage of the labor force and as a percentage of total tertiary graduatesResearcher concentration : Professionals engaged in R&D per 1 million peoplePatent activity : Resident patent filings per 1 million residents and per $1 million of R&D spent
![Page 18: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/18.jpg)
Research & Innovation(R&I) center
Based at the campus of Ewha Univ., Solvay will have access to a strong national and international network with universities and research institutes.
Source : SOLVAY Website (June, 2014)
Case of Industry-University Cooperation
Solvay’s “Global Business Unit Specialty Chemicals”
![Page 19: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/19.jpg)
Overview of KOTRA1
2 Pharma Industry in Korea
3 Innovative Business Trends
![Page 20: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/20.jpg)
KOTRA Headquarters
![Page 21: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/21.jpg)
Ministry of Trade, Industry & Energy Ministry of Trade, Industry & Energy
TRADE PromotionTRADE Promotion INVESTMENT PromotionINVESTMENT Promotion
National IPA : Invest Korea21
![Page 22: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/22.jpg)
Grievance resolution, employees search
Market research,Partner Search,Site Survey …
Gov’s Incentive Consultations,Administrative support, … Pre-Investment
Execution
Aftercare
One-Stop Service for Foreign Investors 22
Government agencies
Local governments
Overseas Network42/122 Business Centers
Project Managers
![Page 23: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/23.jpg)
Supporting Process of GOV. Incentives
23
23
![Page 24: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/24.jpg)
Overview of KOTRA 1
2 Pharmaceutical Industry in Korea
3 Innovative Business Trends
![Page 25: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/25.jpg)
Pharmaceutical Market PrognosisOpportunities in Emerging Market
![Page 26: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/26.jpg)
Sustainable Growth in Korea
CHINA
JAPAN
Opportunities in Emerging Market
![Page 27: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/27.jpg)
Export Import Production Market Size
Unit : USD Billion
Korea Pharmaceutical Market
Source: KFDA (2014.2)
US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking20% Annual Increasing Rate of Export
![Page 28: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/28.jpg)
Korean Pharmaceutical Market
Unit : USD thousand Source: KFDA (2014.2)
Major Exporting Countries (`11)
![Page 29: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/29.jpg)
* Colored mark : Foreign invested MNC company Source: Each company’s annual report / DART (2013 04)
Rank Company
Total Sales
2010 2011 2012 Growh Rate
1 Dong-A 846.8 907.3 930.9 3%
2 Yuhan Co. 649.3 667.6 762.7 14%
3 Greencross 791 698.9 715.5 2%
4 Dae-woong 672.2 711.1 664 -6%
5 Hanmi 595 512.5 543.7 6%
6 GSKKorea 465 506.2 473.2 -6.5%
7 NovartisKorea 435.8 478.8 463.5 -3.2%
8 CKDPharm 419.6 442.2 461 4%
9 PfizerKorea 422.8 452.7 418.8 -7.5%
10 Jeil Pharm 431.3 462.9 426.8 -8%
Rank Company
Total Sales
2010 2011 2012 Growth Rate
11 LG Life Science 334.3 372.
5 397.6 7%
12 Choong-wae 443.3 431 397 -8%
13 Kwang Dong 289.4 313.
3 331.8 6%
14 BayerKorea 342.8 355.
5 330.9 -6.9%
15 Il-dong 338 338.5 326 2%
16 Handok 321 333.2 314.6 -5%
17 Boryung 301 308 312 1%
18Sanofi
-Aventis Korea
428 344 283.6 -17.5%
19 AstrazenecaKorea 247.3 261.
8 270.2 3.2%
20 RocheKorea 252 218.
9 262.9 20.1%
Rank Company
Total Sales
2010 2011 2012 Growh Rate
21 Dongwha 215.3 234.6 223.3 -5%
22 Janssen Korea 210.3 232 218.6 -5.8%
23 ShinPoong 225.7 224.9 212 -6%
24 Wyeth Korea 161.7 184.2 201.4 9.4%
25 Berna Biotech 277.9 248 186.4 -
24.8%
26 Samjin 200.4 201.8 185.7 -7.96%
27 Roche Diagnostics 143.7 170 183.4 8%
28 Dong Kook 140.4 160.3 180.2 12%
29
Bboehringer-
ingelheim Korea
148.8 175.2 18.3%
30 Abbot Korea 174.4 169.2 -3%
(Unit: KRW Billion, %)- 60% Final drug’s production from Top 30, Top 5 Local players
![Page 30: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/30.jpg)
Exporting construction know-hows to the developing countries
Blood Preparation Plant of Green Crossin Thailand
IV Solution MFG Plant of JW pharm in Kazakhstan
![Page 31: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/31.jpg)
![Page 32: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/32.jpg)
![Page 33: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/33.jpg)
![Page 34: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/34.jpg)
-Biologics CMO plant in Incheon FEZ (‘11.5)
-Biz for R&D, sales and marketing of Biologics(’12.1)
-M&A (‘11.2)
![Page 35: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/35.jpg)
![Page 36: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/36.jpg)
No. of in-patient beds per 1,000 inhabitants
![Page 37: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/37.jpg)
“As one of the fastest growing country in Asia in terms of clinical area, Korea has competitive factors thoroughly in
high level open research labor, cost and quality, etc.”
Joe Feczko, Senior Vice President, Chief Medical Officer
“As one of the fastest growing country in Asia in terms of clinical area, Korea has competitive factors thoroughly in
high level open research labor, cost and quality, etc.”
Joe Feczko, Senior Vice President, Chief Medical Officer
![Page 38: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/38.jpg)
![Page 39: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/39.jpg)
![Page 40: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/40.jpg)
Medical Healthcare Technology
Smart Hospital System of patient guide application and bedside station
Robotic System in Operating Room Dr. Lee Sung-gyu Liver Transplantation
![Page 41: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/41.jpg)
Disruptive Innovation using Lab-On-a-Chip Technology
![Page 42: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/42.jpg)
![Page 43: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/43.jpg)
Government Policy and Support
Innovative Company Selection and Support (`13~)- incentive expansion for companies to concentrate on R&D
Development and Commercialization Support - CRO nurturing, CMO activation, Partnerships, M&A
Promoting Bio clusters : Daegu Medivally, Osong BiovalleyBio-Fund / Global Pharma Fund …
Stem Cell Research / Brain Disease Research / Genome Projects- Support for clinical trials, approval process, basic research
Korean Drug Development Fund (KDDF) : R&D matching fund (US$1,000M, `11-`20)National Onco Venture (NOV) : R&D matching fund (US$240M, `11-`16)
![Page 44: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/44.jpg)
![Page 45: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/45.jpg)
International Joint R&D Development Initiatives Incentives
Global Advanced Technology Development Program - Advance Technology Center : ATC track for foreign invested co. - Target : SMEs, FDIed R&D centers, research institutes and universities- Organization : KEIT
Int’l Cooperation Programs
- Bilateral Cooperation / Multilateral Cooperation- Target : Global market-oriented technology development of Korean enterprise- Organization : KIAT
![Page 46: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/46.jpg)
International Joint R&D Development Initiatives Incentives
Global Advanced Technology Development Program - Advance Technology Center : ATC track for foreign invested co. - Target : SMEs, FDIed R&D centers, research institutes and universities- Organization : KEIT
Int’l Cooperation Programs
- Bilateral Cooperation / Multilateral Cooperation- Target : Global market-oriented technology development of Korean enterprise- Organization : KIAT
![Page 47: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/47.jpg)
Partnerships & Collaborations
![Page 48: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/48.jpg)
Overview of KOTRA 1
2 Biopharma Industry in Korea
3 Open Innovation Trends
![Page 49: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/49.jpg)
• KRW 20 Billion investment plan
only in Korea for next 5 yrs
• “Novartis Venture Fund” invested in 3
Korean Bio-ventures through GAPS
• Working group with KOTRA and KHIDI, …
• Quroscience (2010) - PhenoScreen Platform Tech., Anti-HIV,
Anti-TB, Anti-HCV
- Affiliation with Institute Pasteur Korea
- GATE II winner
- CEO : Dr. Ulf Nehrbrass
• PharmAbcine (2009) - Bi-specific Ab against VEGF-receptor target
- Affiliation with KRIBB
- CEO&Founder: Dr. Jin-San Yoo
- Syndicated investment by OrbiMed (US),
GrGeenCross investment(Kr)…(USD 6M)
• Neomics(2008)-siRNA tech. for Novel cancer
target; multiple modalities
-CEO: Mr. Chiuk In
-Founder: Prof. Sunghoon Kim,
from Seoul National University
Global Alliance Projects (‘08, ‘10)
Biz. Cases
GAPS Launching Conference, Seoul, Mar. 18th, 2010
![Page 50: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/50.jpg)
Biz. Cases
![Page 51: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/51.jpg)
• Phase 1 Clinical Trial is in progress- Lung and gastric cancer new drug candidate substance
R&D Collaboration CasesBiz Cases
Source : Domestic CRO and Global Pharmaceutical work together, Dong-A, 2013.6.26 , www.lskglobal.com, 2013
![Page 52: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/52.jpg)
Biz. Cases
2012.05 2012.08
“Open Innovation“
New drug development and commercialization with Lego ChemBio.
Lego Chem Bio has new drug composite technologies (LegoChemistry) and the early pharmacometrics technologies.
“Platform for incurable disease“
Sanofi and Bioneer work together in solid cancer using nanoparticle medicine(SAMiRNA) developed by Bioneer
They will verify the effectiveness of target gene and start clinical trials about new drug candidates.
![Page 53: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/53.jpg)
OPEN INNOVATION AND NETWORKING
- Offer opportunities to work within alliance with complementary companies
TAPPING INTO REGIONAL INNOVATIVE STRENGTHS
- Source local capital, labor, knowledge and creativity
WE BID TO WIN
- Jointly develop and win projects aligned with policy initiatives
Concluding Thoughts
![Page 54: Pharma Innovation at Korea - İEİS...Unit : USD Billion Korea Pharmaceutical Market Source: KFDA (2014.2) US$16billion Market with CAGR 7% (`02-`12) 14th ~ 15th Global Ranking 20%](https://reader035.vdocument.in/reader035/viewer/2022071217/604ac8f1e4b53a4e8068d0ee/html5/thumbnails/54.jpg)
For our Growth Proposition
1
We Need “Open Innovation”
Human ResourcesTechnology
Clinical Trials
System
Medical Application
Fund-raising
Policy Support